BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...LinkMed's stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag...
...AB. It was created in 2009 to acquire and manage Olerup GmbH's distribution rights for NorDiag's...
...HLA) and XM-ONE products from Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN, Venlo, the Netherlands). Following the divesture, NorDiag...
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...LinkMed's stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag...
...AB. It was created in 2009 to acquire and manage Olerup GmbH's distribution rights for NorDiag's...
...HLA) and XM-ONE products from Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN, Venlo, the Netherlands). Following the divesture, NorDiag...
BioCentury | Feb 22, 2010
Company News

Molzym GmbH & Co. KG, NorDiag deal

...detects DNA from 345 strains of bacterial, yeast and fungal pathogens isolated from human samples. NorDiag...
...will contribute its Arrow low throughput nucleic acid extraction instrument, and Molzym will contribute reagents. NorDiag...
...expect to launch the diagnostic next quarter. Molzym GmbH & Co. KG , Bremen, Germany NorDiag ASA...
BioCentury | Feb 1, 2010
Financial News

NorDiag completes rights offering

NorDiag ASA (OSE:NORD), Oslo, Norway Business: Diagnostic, Supply/Service Date completed: 1/18/10 Type: Rights offering Raised: NOK8 million ($1.4 million) Shares: 8 million Price: NOK1 Shares after offering: 62.1 million Placement agent: DnB NOR Markets Investors:...
BioCentury | Jun 11, 2007
Company News

Exact Sciences, NorDiag deal

...EXAS will receive an undisclosed licensing fee, plus royalties. Exact Sciences Corp. (EXAS), Marlborough, Mass. NorDiag ASA...
BioCentury | May 7, 2007
Company News

NorDiag, General Electric deal

...infectious diseases and markets Genefec, a diagnostic for colorectal cancer. Financial terms were not disclosed. NorDiag ASA...
BioCentury | Feb 13, 2006
Company News

NorDiag, Transgenomic sales and marketing update

...TBIO granted NorDiag exclusive European commercialization rights to TBIO's Wave system to detect colorectal and pancreatic...
...NorDiag will pay a license fee and will make certain minimum annual purchases from TBIO. NorDiag ASA...
BioCentury | Jun 20, 2005
Company News

Genzyme, Novel Diagnostics ASA deal

...Novel Diagnostics' NorDiag AS unit licensed European rights to GENZ's p53 and APC genes. NorDiag plans...
Items per page:
1 - 8 of 8
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...LinkMed's stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag...
...AB. It was created in 2009 to acquire and manage Olerup GmbH's distribution rights for NorDiag's...
...HLA) and XM-ONE products from Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN, Venlo, the Netherlands). Following the divesture, NorDiag...
BioCentury | May 30, 2011
Company News

NorDiag, LinkMed AB deal

...LinkMed's stake in Olerup International to 75% from 25%. Olerup International is a JV between NorDiag...
...AB. It was created in 2009 to acquire and manage Olerup GmbH's distribution rights for NorDiag's...
...HLA) and XM-ONE products from Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN, Venlo, the Netherlands). Following the divesture, NorDiag...
BioCentury | Feb 22, 2010
Company News

Molzym GmbH & Co. KG, NorDiag deal

...detects DNA from 345 strains of bacterial, yeast and fungal pathogens isolated from human samples. NorDiag...
...will contribute its Arrow low throughput nucleic acid extraction instrument, and Molzym will contribute reagents. NorDiag...
...expect to launch the diagnostic next quarter. Molzym GmbH & Co. KG , Bremen, Germany NorDiag ASA...
BioCentury | Feb 1, 2010
Financial News

NorDiag completes rights offering

NorDiag ASA (OSE:NORD), Oslo, Norway Business: Diagnostic, Supply/Service Date completed: 1/18/10 Type: Rights offering Raised: NOK8 million ($1.4 million) Shares: 8 million Price: NOK1 Shares after offering: 62.1 million Placement agent: DnB NOR Markets Investors:...
BioCentury | Jun 11, 2007
Company News

Exact Sciences, NorDiag deal

...EXAS will receive an undisclosed licensing fee, plus royalties. Exact Sciences Corp. (EXAS), Marlborough, Mass. NorDiag ASA...
BioCentury | May 7, 2007
Company News

NorDiag, General Electric deal

...infectious diseases and markets Genefec, a diagnostic for colorectal cancer. Financial terms were not disclosed. NorDiag ASA...
BioCentury | Feb 13, 2006
Company News

NorDiag, Transgenomic sales and marketing update

...TBIO granted NorDiag exclusive European commercialization rights to TBIO's Wave system to detect colorectal and pancreatic...
...NorDiag will pay a license fee and will make certain minimum annual purchases from TBIO. NorDiag ASA...
BioCentury | Jun 20, 2005
Company News

Genzyme, Novel Diagnostics ASA deal

...Novel Diagnostics' NorDiag AS unit licensed European rights to GENZ's p53 and APC genes. NorDiag plans...
Items per page:
1 - 8 of 8